To FDA on labeling of plant-based milk alternatives and voluntary nutrient statements
GFI urges FDA to treat plant-based milks fairly and avoid any labeling scheme that would unfairly burden one class of products in the marketplace.
GFI urges FDA to treat plant-based milks fairly and avoid any labeling scheme that would unfairly burden one class of products in the marketplace.
GFI's comment supports a cautious and flexible approach towards labeling as cultivated seafood comes to market. Learn why we support regulatory flexibility for cultivated seafood.
GFI urges FDA to establish principles for modernizing food standards that account for all foods. Learn why doing so is vital to FDA’s goal of supporting innovation.
GFI’s supplement highlights market developments since submitting its Citizen Petition. Learn why the developments demonstrate a need for clarity from FDA.
GFI’s comment encourages FDA to clarify that new foods may be named by reference to the names of other foods. Learn why doing so supports FDA’s goal of promoting innovation.
GFI’s supplement highlights two new legal developments since submitting its Citizen Petition. Learn why the developments demonstrate a need for clarity from FDA.
GFI’s petition requests FDA to clarify that new foods may be named by reference to the names of other foods. Learn why doing so would be in line with consumer understanding.